Stockreport

ALX Oncology Spotlights Evorpacept HER2 Strategy and EGFR ADC ALX2004 Progress at JPM Conference [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF Morgan conference led by CEO Jason Lettmann and Chief Medical Officer Barbara Klencke. Management highlighted what it described as an “incredible year” of multiple dat [Read more]